Optimizing Antithrombotic Care in Patients With AtriaL fibrillatiON and Coronary stEnt (OAC-ALONE) Study

PHASE4CompletedINTERVENTIONAL
Enrollment

690

Participants

Timeline

Start Date

November 5, 2013

Primary Completion Date

May 18, 2017

Study Completion Date

May 18, 2018

Conditions
Atrial FibrillationCoronary Artery Disease
Interventions
DRUG

OAC alone

Single APT with either aspirin or clopidogrel is discontinued in this arm.

Trial Locations (1)

606-8507

Kyoto University Graduate School of Medicine, Kyoto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Research Institute for Production Development

UNKNOWN

collaborator

Daiichi Sankyo Co., Ltd.

INDUSTRY

lead

Satoshi Shizuta

OTHER